Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

Condition(s) targeted: Over Active Bladder

Intervention: Fesoterodine (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Overall contact:
Pfizer CT.gov Call Center, Phone: 1-800-718-1021

This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.

Official title: Post Marketing Surveillance To Assess The Safety And Efficacy Of Fesoterodine (Toviaz) On Filipino Patients Diagnosed With Over-Active Bladder

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome:

Number of participants with adverse events as a measure of safety.

Number of micturitions per 24 hours as a measure of efficacy.

Number of urgency episodes per 24 hours as a measure of efficacy.

Number of urgency urinary incontinence (UUI) episodes per 24 hours as a measure of efficacy.

Patient perception of bladder condition as a measure of efficacy.

Detailed description: Sampling method is not applicable in this study. Only patients prescribed Fesoterodine will be enrolled.

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Over-active bladder

- Prescribed with Fesoterodine

Exclusion Criteria:

- Hypersensitivity

- Urinary retention

Pfizer CT.gov Call Center, Phone: 1-800-718-1021

Private Clinic, Baguio City, Philippines; Recruiting

Private Clinic, Batangas, Philippines; Recruiting

Cebu Doctors Hospital, Osmena Blvd.,, Cebu, Philippines; Recruiting

Davao Medical School Foundation Hospital, Davao, Philippines; Recruiting

Davao Doctors Hospital, Davao, Philippines; Recruiting

Private Clinic, Davao City, Philippines; Recruiting

Davao Doctors Tower, Davao City, Philippines; Recruiting

Room 120, Davao Medical School Foundation Hospital, Davao City, Philippines; Recruiting

Private Clinic, Ilocos Norte, Philippines; Recruiting

Private Clinic, La Union, Philippines; Recruiting

Private Clinic, Laguna, Philippines; Recruiting

Lucena United Doctors Hospital, Lucena City 4301, Philippines; Recruiting

Private Clinic, Makati City, Philippines; Recruiting

Makati Medical Center, Makati City 1200, Philippines; Recruiting

Room 314 Main Building, Makati City, Philippines; Recruiting

VRPMC, Mandaluyong, Philippines; Recruiting

Medical Center Manila, Manila 1000, Philippines; Recruiting

University of Sto. Tomas Hospital, Manila 1000, Philippines; Recruiting

Santo Tomas University Hospital, Manila, Philippines; Recruiting

Ospital ng Maynila Medical Center, Manila, Philippines; Recruiting

Private Clinic, Manila, Philippines; Recruiting

Private Clinic, Muntinlupa City, Philippines; Recruiting

Private Clinic, Nueva Ecija, Philippines; Recruiting

Healthway Medical, The Block, Philippines, Philippines; Recruiting

East Avenue Medical Center, Quezon, Philippines; Recruiting

Private Clinic, Quezon, Philippines; Recruiting

Private Clinic, Quezon City, Philippines; Recruiting

St. Luke's Medical Center, North Tower, CHBC, Quezon City 1100, Philippines; Recruiting

Private Clinic, South Luzon, Philippines; Recruiting

Central Luzon Doctor's Hospital, Tarlac City, Philippines; Recruiting

Fatima Medical Center, Inc., Valenzuela, Philippines; Recruiting

F.E.U. - Nicanor Reyes Medical Foundation Medical Center, West Fairview, Quezon City 1100, Philippines; Recruiting

Urology Clinic, Zamboanga City, Philippines; Recruiting

Mary Johnston Hospital, Inc., Tondo, Manila 1000, Philippines; Recruiting

East Avenue Medical Center, Diliman, Quezon City, Metro Manila 1101, Philippines; Recruiting

The Medical City, Pasig City, Metro Manila 1605, Philippines; Recruiting

St. Luke's Medical Center, Quezon City, Metro Manila 1102, Philippines; Recruiting

To obtain contact information for a study center near you, click here.

Starting date: February 2011
Last updated: February 5, 2013